Kali Zhou

1.4k total citations
50 papers, 655 citations indexed

About

Kali Zhou is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Kali Zhou has authored 50 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hepatology, 39 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Kali Zhou's work include Liver Disease Diagnosis and Treatment (31 papers), Hepatitis C virus research (23 papers) and Hepatitis B Virus Studies (19 papers). Kali Zhou is often cited by papers focused on Liver Disease Diagnosis and Treatment (31 papers), Hepatitis C virus research (23 papers) and Hepatitis B Virus Studies (19 papers). Kali Zhou collaborates with scholars based in United States, China and Philippines. Kali Zhou's co-authors include Norah A. Terrault, Carla S. Coffin, Joseph D. Tucker, Evans Whitaker, Thomas Fitzpatrick, Jennifer L. Dodge, Mellanye Lackey, Nick Walsh, Ji Young Kim and Roger Chou and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Kali Zhou

44 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kali Zhou United States 13 512 510 72 55 39 50 655
Sergio Rodríguez‐Tajes Spain 15 697 1.4× 660 1.3× 96 1.3× 64 1.2× 25 0.6× 48 879
Ricardo Franco United States 13 377 0.7× 359 0.7× 102 1.4× 40 0.7× 26 0.7× 43 514
Bożena Walewska‐Zielecka Poland 11 380 0.7× 361 0.7× 51 0.7× 27 0.5× 30 0.8× 41 520
Gibril Ndow United Kingdom 12 581 1.1× 623 1.2× 91 1.3× 32 0.6× 42 1.1× 32 729
Xien Gui China 15 165 0.3× 346 0.7× 234 3.3× 47 0.9× 50 1.3× 33 562
Eleftheria Zervou Greece 15 378 0.7× 339 0.7× 68 0.9× 24 0.4× 21 0.5× 26 592
Faleh Z. Al-Faleh Saudi Arabia 15 578 1.1× 602 1.2× 56 0.8× 54 1.0× 15 0.4× 40 777
Vincenzo Guadagnino Italy 15 822 1.6× 752 1.5× 104 1.4× 19 0.3× 24 0.6× 42 950
Maryam Darvishian Canada 14 432 0.8× 434 0.9× 123 1.7× 6 0.1× 32 0.8× 34 562
Qianli Yuan China 8 228 0.4× 296 0.6× 71 1.0× 13 0.2× 18 0.5× 17 368

Countries citing papers authored by Kali Zhou

Since Specialization
Citations

This map shows the geographic impact of Kali Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kali Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kali Zhou more than expected).

Fields of papers citing papers by Kali Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kali Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kali Zhou. The network helps show where Kali Zhou may publish in the future.

Co-authorship network of co-authors of Kali Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Kali Zhou. A scholar is included among the top collaborators of Kali Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kali Zhou. Kali Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Kali, Christopher K. Wong, Amol S. Rangnekar, et al.. (2025). Immigration Factors and Monitoring of Chronic Hepatitis B Infection Among Foreign‐Born: The FOCUS‐HBV Multicentre Cohort. Alimentary Pharmacology & Therapeutics. 61(12). 1913–1922.
2.
Zhou, Kali, Laura Thompson, Jennifer L. Dodge, et al.. (2025). Longer travel and traffic are associated with adult liver transplant waitlist mortality in the United States. American Journal of Transplantation. 25(7). 1515–1525.
3.
Tabrizian, Parissa, Julio R. Gutiérrez, Maarouf Hoteit, et al.. (2025). Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multicenter prospective cohort study. Hepatology. 82(3). 612–625. 3 indexed citations
4.
Mallepally, Niharika, Layla Shojaie, Evanthia T. Roussos Torres, et al.. (2025). High Grade Hepatotoxicity From Dual Checkpoint Inhibitors Is More Common in Hepatocellular Carcinoma Than Other Cancers. Liver International. 45(9). e70255–e70255.
5.
Zhou, Kali, Sachin Shah, Laura Thompson, & Neil Mehta. (2024). Bridging the rural-urban gap in access to liver transplantation. Clinical Liver Disease. 23(1). e0160–e0160. 3 indexed citations
6.
Zhou, Kali, Lauren Nguyen, Parissa Tabrizian, & Neil Mehta. (2024). Sociodemographic disparities in downstaging to liver transplant for hepatocellular carcinoma. Liver Transplantation. 31(4). 556–559.
7.
Hundt, Melanie, et al.. (2024). Barriers to liver transplant referral in safety net settings: A national provider survey. Liver Transplantation. 30(9). 896–906. 3 indexed citations
8.
Zhou, Kali, et al.. (2024). Country-Specific Screening, Prevalence, and Immunity Rates for Hepatitis B Infection in a Large US Safety-Net System. Open Forum Infectious Diseases. 11(1). ofad699–ofad699. 3 indexed citations
9.
Zhou, Kali, Ziwei Song, Jennifer L. Dodge, et al.. (2023). Association of nativity with survival among adults with hepatocellular carcinoma. JNCI Journal of the National Cancer Institute. 115(7). 861–869. 6 indexed citations
10.
Zhou, Kali, Paulo S. Pinheiro, Iona Cheng, et al.. (2023). Increasing risk of hepatocellular carcinoma with successive generations in the United States among Mexican American adults: The Multiethnic Cohort. Cancer. 130(2). 267–275. 4 indexed citations
11.
Bangaru, Saroja, et al.. (2023). Care for Vulnerable Populations with Chronic Liver Disease: A Safety-Net Perspective. Healthcare. 11(20). 2725–2725. 1 indexed citations
12.
Zhou, Kali, et al.. (2023). Population‐attributable risk of modifiable lifestyle factors to hepatocellular carcinoma: The multi‐ethnic cohort. Alimentary Pharmacology & Therapeutics. 58(1). 89–98. 7 indexed citations
13.
14.
Zhou, Kali, et al.. (2021). Qualifiction of proteomic biomarkers for knee osteoarthritis progression. Osteoarthritis and Cartilage. 29. S7–S8. 1 indexed citations
15.
Zhou, Kali, Trevor A. Pickering, Myles Cockburn, et al.. (2020). Presentation, Management, and Outcomes Across the Rural-Urban Continuum for Hepatocellular Carcinoma. JNCI Cancer Spectrum. 5(1). 15 indexed citations
16.
Adeniji, Nia, Elizabeth S. Aby, Ponni Perumalswami, et al.. (2020). PREDICTORS OF OUTCOMES OF COVID-19 IN PATIENTS WITH CHRONIC LIVER DISEASE: US MULTI-CENTER STUDY. Hepatology. 72. 1 indexed citations
17.
Zhou, Kali, et al.. (2019). Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses. ˜The œLancet. Gastroenterology & hepatology. 4(3). 227–238. 79 indexed citations
18.
Coffin, Carla S., Kali Zhou, & Norah A. Terrault. (2018). New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Virus Infection. Gastroenterology. 156(2). 355–368.e3. 90 indexed citations
19.
Zhou, Kali, Charles Wang, Fengyu Hu, et al.. (2016). Natural Polymorphisms Conferring Resistance to HCV Protease and Polymerase Inhibitors in Treatment-Naïve HIV/HCV Co-Infected Patients in China. PLoS ONE. 11(6). e0157438–e0157438. 9 indexed citations
20.
Saab, Sammy, et al.. (2015). De novo Hepatocellular Carcinoma after Liver Transplantation. Journal of Clinical and Translational Hepatology. 3(4). 284–287. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sergio Rodríguez‐Tajes Breakdown of academic impact, for papers by Ricardo Franco Breakdown of academic impact, for papers by Bożena Walewska‐Zielecka Breakdown of academic impact, for papers by Gibril Ndow Breakdown of academic impact, for papers by Xien Gui Breakdown of academic impact, for papers by Eleftheria Zervou Breakdown of academic impact, for papers by Faleh Z. Al-Faleh Breakdown of academic impact, for papers by Vincenzo Guadagnino Breakdown of academic impact, for papers by Maryam Darvishian Breakdown of academic impact, for papers by Qianli Yuan
Rankless by CCL
2026